Avantgarde Financial Systems · New York
Avantgarde Financial Systems is a structured finance and alternative-asset platform operating across three converging opportunities: distressed asset acquisition, defense-adjacent technology, and human performance and regenerative health.
Select your perspective
01 — Platform
Each opportunity represents a distinct dislocation in the current market — pricing inefficiencies in winding-down credit, procurement pathways opening across the federal, state and local, and defense ecosystem, and an emerging class of dual-use and regenerative technologies positioned ahead of institutional demand. Avantgarde was structured to source, underwrite and operate across all three — not as separate verticals but as complementary channels through which capital can be deployed, value extracted and liquidity created.
A growing inventory of undervalued IP, revenue-generating subsidiaries and discounted debt obligations from 2018–2022 vintage funds approaching wind-down without clean exits. We source, structure and recapitalize distressed positions — debt portfolios, stranded IP and asset-backed credit facilities — and create liquidity where the market has stalled.
Architecture node
Cingularity
A neuro-wearable interface supporting adaptive monitoring and command pathways.
Operating DNA
Distressed Venture Capital Fund
The firm is the institutional evolution of a platform that began as a capital advisory practice, venture studio and distressed venture capital fund — founded after more than a decade of operating and building companies across AI, fintech and emerging technology. The advisory practice established the dealflow relationships and underwriting discipline; the venture studio built the muscle for standing up, restructuring and scaling companies; and the distressed venture capital fund instilled the capital-allocation rigor that governs how we evaluate and structure every position.
Advisory
Venture Studio
Fund
Institutional Platform
02 — Defense
Critical Intelligence & Safety Infrastructure
Velkaris Aviation is a medical, ISR and defense unmanned aircraft systems company, positioned for defense, public safety and first-response operators. Velkaris is design authority for its UAS technology, pairing hardened airframes with an integrated battlefield medical and diagnostics payload — operated through a proprietary neuro-wearable control interface.
Intelligence, surveillance and reconnaissance mission sets; persistent aerial overwatch.
Protect the body. Restore the mind.
Force protection that prevents the injuries regenerative care would otherwise need to repair. Proven first in domestic public-safety environments, scaled to defense.
Revitalizing America
A commitment to domestic precision manufacturing, skilled aerospace and defense jobs in American communities, supply-chain security, and partnerships with AS9100-grade U.S. manufacturers.
Public sector touchpoints · Direct / indirect settlement
Distribution channels
03 — Health
Making American Soldiers Next to Immortal
Our regenerative health vertical brings together non-invasive modalities — photobiomodulation (red-light), pulsed electromagnetic field (PEMF) therapy and neural monitoring — with AI-adaptive protocols, designed for the veteran, active-duty and first-responder communities. The pathway runs through clinical partnerships, federal research programs and certified manufacturing.
Neuro-wearable headset · BCI/MMI
Adaptive neural-state monitoring.
Continuous neural-state monitoring paired with targeted, adaptive protocols that personalize over time. The same interface underpins Velkaris neural command.
Products described are in development; no medical claims are made. Regulatory pathways pursued as applicable.
Healthcare readiness supply
From field response to hospital readiness.
Field and hospital readiness supplies, including diagnostic and wound-care kits, pursued through cGMP-certified manufacturing pathways.
Lazarus Regenerative Medicine
Next-Gen Tissue Restoration
Advanced Regenerative Healing
Making Soldiers and others superhuman and/or next to immortal.
Proprietary Defense Application
Programs described are in development or subject to contract; no medical claims are made. Regulatory pathways pursued as applicable.
04 — Capital
Our mandate spans distressed debt settlement, asset swaps, trading and liquidity access, structured and asset-backed facilities, and special-situation recapitalizations. We combine capital markets judgment with operating execution to move assets from dislocation toward durable value.
How we engage
Share the opportunity and key transaction context.
05 — Leadership
Chief Executive Officer & Co-Founder
Micah's career spans risk management software at Barclays, AI-driven tooling at Aon, and graduate study in private equity at Columbia. Over the past decade he has built and exited companies across AI, behavioral data and financial technology, including ventures recognized by Fast Company and MIT. He has participated in five structured exits, one of which was a transaction into a publicly traded acquirer. Long-standing membership in New York private equity and technology networks anchors the firm's dealflow and operator relationships.
President & Co-Founder
Vipul has strategized and advised on institutional capital strategy and deployment — including risk management — and multi-jurisdictional financial structuring across a globally oriented banking and investment platform. With more than two decades at the intersection of institutional finance, strategic advisory and complex asset execution, he has participated in, advised on or evaluated institutional transactions spanning infrastructure, commercial real estate, industrial manufacturing, strategic resource assets and cross-border operating platforms. His background includes institutional banking and enterprise risk experience with organizations including JPMorgan Chase, City National Bank and Cigna Health, informing a disciplined approach to governance, credit oversight, capital preservation and liquidity management.
06 — Partners
Patented electric cold-jet propulsion and 100% electric aircraft spanning cargo, emergency services and tactical defense — including unmanned platforms for U.S. defense customers, with low observable signatures, hot-swap batteries and fixed-point takeoff and landing.
Technology licensing and syndication vehicle for aviation platforms.
A BioTech holding company closing the genomic representation gap — transforming ethically sourced genomic and clinical data from underrepresented populations into decision-grade insights for drug discovery, therapeutic development and precision health. Building the world's largest genomic biobank of diversified populations.
Precision manufacturing for unmanned aviation systems.
Further detail provided under separate cover.
A state-of-the-art technology with market-leading versatility within the existing neuro-wearable space, with advanced applications ranging from health to aviation.
Insights
Institutional perspectives, transaction notes and technical briefings.
[Editorial program to be supplied]
07 — Engage
Direct your inquiry to the team best positioned to assess it. Investor materials are shared only after review and, where appropriate, under NDA.